Xiao-Chai-Hu-Tang attenuated the expression of proliferating cell nuclear antigen and epidermal growth factor in a rat model of hepatic fibrosis

Mid-Taiwan Journal of Medicine

Volumn 13, Issue 2, 2008, Pages 65-74

  Chen, Ming Ho ^a,b   Chen, Jung Chou ^a   Tsai, Chin Chuan ^a,c   Wang, Wen Chuang ^b   Hsieh, Hsiao Yen ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

Bile duct ligation; Epidermal growth factor; Liver fibrosis; Proliferating cell nuclear antigen; Xiao Chai Hu Tang

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; XIAO CHAI HU TANG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION;

EID: 48049084956     PISSN: 10293507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. [Review] FASEB J 1995;9:1527-36.
2. Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 1992; 15:707-13.
3. Tuchweber B, Desmouliere A, Bochaton-Piallat ML, et al. Proliferation and phenotypic modulation of portal fibroblasts in the early stage of cholestatic fibrosis in the rat. Lab Invest 1996;74:265-78.
4. Mullhaupt B, Feren A, Fodor E, et al. Liver regeneration of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration. J Biol Chem 1994;269:19667-70.
5. Napoli J, Prentice D, Niinami C, et al. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 1997;26:624-33.
6. Zimmermann H, Ganz P, Zimmermann A, et al. The overexpression of proliferating cell nuclear antigen in biliary cirrhosis in the rat and its relationship with epidermal growth factor receptor. J Hepatol 1995;23: 459-64.
7. Sakae A, Masakane H, Yukio O, et al. Treatment of chronic liver injury in mice by oral administration of Xiao-Chai-Ru-Tang. J Ethnopharmacol 1989;25:181-7.
8. Chen MH, Chen JC, Tsai CC, et al. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats. Am J Chin Med 2004;32:195-207.
9. Sakaida I, Matsumura Y, Akiyama S, et al. Herbal medicine sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rats liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 1998;28:298-306.
10. Shimizu I, Ma YR, Mizobuchi Y, et al. Effect of Shosaiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999;29:149-60.
11. Plebani M, Panozzo MP, Basso D, et al. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol 1999; 26:358-63.
12. Hsu SM, Raine L, Ranger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1981;29:557-80.
13. Iredale JP, Benyon RC, Arthur MJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176-84.
14. Lee HS, Huang GT, Miau LH, et al. Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis. Hepatogastroenterology 2001;48: 1114-7.
15. Gerling B, Becker M, Waldschmidt J, et al. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J Hepatol 1996;25:79-84.
16. Boigk G, Stroedter L, Herbst H, et al. Silymarin retard collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997;26:643-9.
17. Bravo R, Fey SJ, Bellatin J, et al. Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to change in the rate of cell proliferation. Exp Cell Res 1981;136:311-9.
18. Celis JE, Bravo R, Larsen PM, et al. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 1984;8:143-57.
19. Gerland P, Defraef C. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989; 22:383-92.
20. Chijiwa K, Nakano K, Kameoka N, et al. Proliferating cell nuclear antigen, plasma fibronection, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats. Surgery 1994; 116:544-9.
21. Abdel-Aziz G, Rescan PY, Clement B, et al. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol 1991;164:167-74.
22. Rockey DC, Boyles JK, Gabbiani G, et al. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992;24:193-203.
23. Marti U, Burwen SJ, Jones AL. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. [Review] Hepatology 1989;9:126-38.
24. Bachem MG, Reiss U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun 1989;162:708-14.
25. Oguey D, Marti U, Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepatocellular mass. Eur J Cell Biol 1992;59:197-95.
26. St. Hilare RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA 1983;80:3797-801.
27. Shimizu I. Sho-saiko-to: Japanese herbs medicine for protection against hepatic fibrosis and carcinoma. [Review] J Gastroenterol Hepatol 2000; 15(Suppl):84-90.
28. Pinzani M, Gesualdo L, Sabbah GM, et al. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989;84:1786-93.
29. Kayano K, Sakaida I, Uchida K. Inhibitory effect of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expression in cultured rat hepatic stellate cells. J Hepatol 1998;29: 642-9.
30. Zhao G, Ozaki I, Mizuta T, et al. Analysis of components and mechanisms of herbal medicine Shosaiko-to (TJ-9) on TGF-beta expression in human Ito cell line LI90. J Gastroenterol Hepatol 2000;15 (Suppl):F34.